AK

Anil Kumar

Director Director DIN 06438067
DIN 06438067 First appointment Feb 2013 Primary industry Construction
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2013
Shareholding value •••• Premium profile

About Anil Kumar

Data last updated:

Anil Kumar was a Director at Nandopal Construction Private Limited (2022–2025) and Managing Director at Akmist Pharmaceutical Private Limited (2013–2016). The companies operate in Construction and Pharma.

DIN 06438067
Primary Designation Director
Industry Construction
First Appointment 08 Feb 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20222017Active
Managing Director08 Feb 20132013₹1.5 Lakh (FY 2022)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nandopal Construction Private Limited
Akmist Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar

Anil Kumar was first appointed on 08 Feb 2013 as Managing Director at Akmist Pharmaceutical Private Limited. The most recent appointment on record is 17 May 2022 at Nandopal Construction Private Limited.

Anil Kumar held 2 earlier board appointments: Nandopal Construction Private Limited (Director, 17 May 2022 to 20 Apr 2025); Akmist Pharmaceutical Private Limited (Managing Director, 08 Feb 2013 to 04 Aug 2016).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available